SAN DIEGO--(BUSINESS WIRE)--Access to healthcare is a fundamental human right. Yet to this day, routine blood testing is limited across the globe. Truvian Health (“Truvian”) is redefining the current global infrastructure through its novel platform, creating a world where central laboratory equivalent blood tests are available anywhere you go.

圣地亚哥--（商业新闻短讯）--获得医疗保健是一项基本人权。然而，迄今为止，常规血液检测在全球范围内受到限制。Truvian Health（“Truvian”）通过其新颖的平台重新定义了当前的全球基础设施，创造了一个可以在任何地方进行中央实验室等效血液检测的世界。

Today, Truvian is announcing an injection of $74 million of capital to be used in part to secure US Food and Drug Administration (FDA) clearance for its blood testing platform..

今天，特鲁维宣布注资7400万美元，部分用于确保美国食品和药物管理局（FDA）批准其血液检测平台。。

In the United States, approximately 50% of adults skip routine blood testing because it is overwhelmingly complex and friction-laden with prolonged turnaround times that result in delayed medical intervention or missed diagnoses leading to significant, avoidable costs to the US healthcare system. Truvian's automated benchtop platform promises to change this by enabling simple, accurate, and comprehensive routine blood tests to be performed in clinics, doctor’s offices and pharmacies.

在美国，大约50%的成年人跳过常规血液检测，因为它极其复杂，并且充满摩擦，周转时间延长，导致医疗干预延迟或漏诊，从而导致美国医疗保健系统产生重大的，可避免的成本。Truvian的自动化台式平台有望通过在诊所、医生办公室和药房进行简单、准确和全面的常规血液检测来改变这一现状。

Over the past twelve months, Truvian has presented data from multiple independent clinical studies demonstrating that results from its platform are equivalent to those produced in a central laboratory across a large panel of tests..

。。

The latest funding round is co-led by Wittington Ventures and Great Point Ventures, with continuing strong support from existing investors, including DNS Capital, Medical Excellence Capital, Tao Capital, TYH Capital, and 7wireVentures.

最新一轮融资由Wittington Ventures和Great Point Ventures共同牵头，现有投资者（包括DNS Capital、Medical Excellence Capital、Tao Capital、TYH Capital和7wireVentures）继续大力支持。

As a part of the round, Shoppers Drug Mart, Canada’s largest pharmacy, joins Truvian as a commercial partner. “Working with our government partners, we believe in advancing technology to better support patient care, including comprehensive blood testing,” said Jeff Leger, president at Shoppers Drug Mart.

。“与我们的政府合作伙伴合作，我们相信先进的技术可以更好地支持患者护理，包括全面的血液检测，”购物者药物交易中心总裁杰夫·莱格说。

“Truvian's novel platform, combined with the convenience of accessing care in pharmacy, will be an amazing step forward in making care more accessible and convenient for patients.”.

“Truvian的新颖平台，再加上在药房获得护理的便利性，将在使患者更容易获得护理方面迈出惊人的一步。”。

Late last year, Shoppers Drug Mart led an onsite evaluation of Truvian which compared results from Truvian’s platform to a traditional central laboratory. Results between Truvian and the central laboratory were concordant, emphasizing the potential utility of Truvian’s solution.

去年年底，购物者药物交易中心领导了对特鲁维的现场评估，将特鲁维平台的结果与传统的中央实验室进行了比较。Truvian和中央实验室之间的结果是一致的，强调了Truvian解决方案的潜在效用。

“These new investments and strategic partnerships further validate our goal to bring convenient, comprehensive testing to primary care, enabling patients and their doctors to make timely decisions affecting their health,” said Jay Srinivasan, chief executive officer of Truvian. “We are on the cusp of delivering what the world needs to counter today’s non-communicable disease burden and unsustainable healthcare costs.”.

Truvian首席执行官杰伊·斯里尼瓦桑（JaySrinivasan）表示：“这些新的投资和战略合作伙伴关系进一步验证了我们的目标，即为初级保健提供方便、全面的检测，使患者及其医生能够及时做出影响其健康的决定。”。“我们即将提供世界所需的东西，以应对当今的非传染性疾病负担和不可持续的医疗保健成本。”。

Truvian is the first company to share evidence that demonstrates a multi-modal platform can achieve clinical performance equivalent to the central laboratory across a large panel of tests with a single sample. To date, Truvian’s integrated platform has been evaluated on more than 50,000 samples across 5,000 donors while achieving a platform run reliability rate of greater than 98%.

Truvian是第一家分享证据的公司，该证据表明多模式平台可以在单个样本的大量测试中实现与中央实验室相当的临床性能。迄今为止，Truvian的集成平台已在5000多个捐赠者中对50000多个样本进行了评估，同时平台运行可靠性达到98%以上。

Truvian has also scaled its instrument and consumable manufacturing capabilities to initiate its clinical trials and early partner access programs..

Truvian还扩大了其仪器和消耗品制造能力，以启动其临床试验和早期合作伙伴获取计划。。

To learn more about Truvian’s platform, visit www.truvianhealth.com

要了解有关Truvian平台的更多信息，请访问www.truvianhealth.com

About Truvian

关于Truvian

Truvian is a transformational healthcare company bringing lab-accurate results anywhere you go, enabling patients to engage healthcare providers to lead healthier lives. With a focus on making routine blood testing accessible, convenient and transparent, Truvian is accelerating the transition to a sustainable healthcare ecosystem through its comprehensive benchtop solution that delivers timely, actionable results to help stop disease before it starts.

Truvian是一家变革性的医疗保健公司，无论你走到哪里，都能带来实验室准确的结果，使患者能够与医疗保健提供者接触，过上更健康的生活。Truvian专注于使常规血液检测变得容易、方便和透明，通过其全面的台式解决方案加速向可持续医疗生态系统的过渡，该解决方案提供及时、可行的结果，以帮助在疾病开始之前阻止疾病。

For more information, visit truvianhealth.com or follow us on LinkedIn and X..

有关更多信息，请访问truvianhealth.com或在LinkedIn和X上关注我们。。